View in EDS

Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial.

Saved in:
Bibliographic Details
Title: Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial.
Authors: Sockel K, Bornhaeuser M, Mischak-Weissinger E, Trenschel R, Wermke M, Unzicker C, Kobbe G, Finke J, Germing U, Mohr B, Greiner J, Beelen D, Thiede C, Ehninger G, Platzbecker U
Corporate Authors: German MDS and Cooperative Transplant Study Group (GCTSG)
Source: Haematologica [Haematologica] 2012 Sep; Vol. 97 (9), pp. e34-5.
Publication Type: Letter; Comment
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22952334
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sockel+K%22">Sockel K</searchLink><br /><searchLink fieldCode="AU" term="%22Bornhaeuser+M%22">Bornhaeuser M</searchLink><br /><searchLink fieldCode="AU" term="%22Mischak-Weissinger+E%22">Mischak-Weissinger E</searchLink><br /><searchLink fieldCode="AU" term="%22Trenschel+R%22">Trenschel R</searchLink><br /><searchLink fieldCode="AU" term="%22Wermke+M%22">Wermke M</searchLink><br /><searchLink fieldCode="AU" term="%22Unzicker+C%22">Unzicker C</searchLink><br /><searchLink fieldCode="AU" term="%22Kobbe+G%22">Kobbe G</searchLink><br /><searchLink fieldCode="AU" term="%22Finke+J%22">Finke J</searchLink><br /><searchLink fieldCode="AU" term="%22Germing+U%22">Germing U</searchLink><br /><searchLink fieldCode="AU" term="%22Mohr+B%22">Mohr B</searchLink><br /><searchLink fieldCode="AU" term="%22Greiner+J%22">Greiner J</searchLink><br /><searchLink fieldCode="AU" term="%22Beelen+D%22">Beelen D</searchLink><br /><searchLink fieldCode="AU" term="%22Thiede+C%22">Thiede C</searchLink><br /><searchLink fieldCode="AU" term="%22Ehninger+G%22">Ehninger G</searchLink><br /><searchLink fieldCode="AU" term="%22Platzbecker+U%22">Platzbecker U</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22German+MDS+and+Cooperative+Transplant+Study+Group+%28GCTSG%29%22">German MDS and Cooperative Transplant Study Group (GCTSG)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2012 Sep; Vol. 97 (9), pp. e34-5.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22952334
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2012.067629
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e34
    Titles:
      – TitleFull: Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sockel K
      – PersonEntity:
          Name:
            NameFull: Bornhaeuser M
      – PersonEntity:
          Name:
            NameFull: Mischak-Weissinger E
      – PersonEntity:
          Name:
            NameFull: Trenschel R
      – PersonEntity:
          Name:
            NameFull: Wermke M
      – PersonEntity:
          Name:
            NameFull: Unzicker C
      – PersonEntity:
          Name:
            NameFull: Kobbe G
      – PersonEntity:
          Name:
            NameFull: Finke J
      – PersonEntity:
          Name:
            NameFull: Germing U
      – PersonEntity:
          Name:
            NameFull: Mohr B
      – PersonEntity:
          Name:
            NameFull: Greiner J
      – PersonEntity:
          Name:
            NameFull: Beelen D
      – PersonEntity:
          Name:
            NameFull: Thiede C
      – PersonEntity:
          Name:
            NameFull: Ehninger G
      – PersonEntity:
          Name:
            NameFull: Platzbecker U
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2012 Sep
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 97
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1